Describe delayed sequence intubation.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Delayed Sequence Intubation (DSI)

Delayed sequence intubation is a technique in which a dissociative dose of ketamine (1–2 mg/kg IV) is administered to facilitate adequate preoxygenation in agitated or delirious patients who cannot tolerate standard preoxygenation, followed 3 minutes later by administration of a neuromuscular blocking agent and intubation. 1, 2

Core Concept and Rationale

DSI is essentially procedural sedation where the "procedure" is preoxygenation itself. 2 The technique addresses a critical clinical problem: patients with altered mental status, agitation, or delirium who actively resist preoxygenation efforts, creating high risk for severe hypoxemia during intubation. 1

  • The British Journal of Anaesthesia guidelines explicitly describe DSI as a practical solution when pre-induction oxygenation becomes difficult in agitated patients. 1
  • DSI allows clinicians to convert an uncooperative, hypoxemic patient into one who can receive optimal preoxygenation before paralysis and intubation. 2

The DSI Protocol: Step-by-Step

Step 1: Patient Assessment and Preparation

  • Identify patients who are agitated, delirious, or combative and cannot tolerate facemask preoxygenation despite their need for definitive airway management. 2, 3
  • Ensure all intubation equipment, rescue devices, and vasopressors are immediately available before beginning. 1

Step 2: Ketamine Administration

  • Administer ketamine 1–2 mg/kg IV (mean effective dose approximately 1.4 mg/kg when titrated). 4, 2
  • Ketamine is preferred because it preserves spontaneous respirations and airway reflexes while providing dissociative sedation. 4
  • The dissociative state typically occurs within 30–60 seconds of administration. 2

Step 3: Preoxygenation Phase (3 Minutes)

  • Once the patient is dissociated and cooperative, apply high-flow nonrebreather mask at 15 L/min or noninvasive positive pressure ventilation (NIPPV) for 3 minutes. 2, 3
  • In critically injured trauma patients, this 3-minute preoxygenation window after ketamine administration significantly improves oxygen saturation levels. 3
  • The British Journal of Anaesthesia recommends using a tight-fitting facemask with CPAP 5–10 cm H₂O if oxygenation is impaired. 1
  • Target end-tidal oxygen fraction (FetO₂) ≥90% or oxygen saturation ≥98% before proceeding. 1, 2

Step 4: Induction and Paralysis

  • After the 3-minute preoxygenation period, administer your neuromuscular blocking agent (succinylcholine 1–1.5 mg/kg IV or rocuronium 0.9–1.2 mg/kg IV). 4, 5
  • No additional induction agent is typically needed because the ketamine provides ongoing sedation during the brief period until paralysis occurs. 2
  • Wait for full neuromuscular blockade (30–45 seconds for succinylcholine, 60 seconds for rocuronium) before attempting laryngoscopy. 4

Step 5: Intubation

  • Proceed with laryngoscopy and intubation using your standard technique. 2
  • Continue nasal oxygen at 15 L/min during intubation attempts (apneic oxygenation). 1

Step 6: Post-Intubation Sedation

  • Critical pitfall: Immediately administer protocolized post-intubation analgosedation, especially if rocuronium was used, because ketamine's dissociative effects wear off well before rocuronium's paralysis resolves (30–60 minutes), creating a high-risk window for awareness. 4
  • Assign a dedicated team member to manage post-intubation sedation timing. 4

Evidence for Efficacy and Safety

Oxygenation Outcomes

  • In a prospective multicenter study of 62 emergency department and ICU patients, DSI increased mean oxygen saturation from 89.9% to 98.8% (mean increase 8.9%, 95% CI 6.4–10.9%). 2
  • Among 32 high-risk patients with baseline saturations ≤93%, 91% achieved saturations >93% after DSI. 2
  • A randomized controlled trial in 200 critically injured trauma patients showed DSI reduced peri-intubation hypoxia from 35% (RSI group) to 8% (DSI group), P = .001. 3

Intubation Success

  • First-attempt intubation success was 83% with DSI versus 69% with conventional RSI (P = .02) in trauma patients. 3
  • All 40 patients receiving DSI from intensive care flight paramedics were successfully intubated with median post-DSI oxygen saturation of 100%. 6

Safety Profile

  • No complications were observed in the original 62-patient DSI cohort. 2
  • In the prehospital setting, only one patient experienced self-limiting apnea <15 seconds after ketamine; no patients required surgical airway or experienced cardiac arrest. 6
  • Post-intubation complications (bradycardia, hypotension, tachycardia, transient desaturation) occurred at low rates comparable to standard RSI. 6

Clinical Indications for DSI

Use DSI when patients meet ALL of the following criteria:

  • Require emergency airway management with definitive intubation. 2
  • Are agitated, delirious, combative, or have altered mental status preventing cooperation. 1, 2, 3
  • Cannot tolerate standard preoxygenation techniques (facemask, NIPPV, high-flow nasal oxygen). 1, 2
  • Are hypoxemic or at high risk for critical desaturation during intubation. 2, 3

Common clinical scenarios include:

  • Traumatic brain injury with agitation. 6, 3
  • Hypoxemic respiratory failure with delirium. 2
  • Intoxication or withdrawal states preventing cooperation. 2
  • Combative patients requiring nasogastric tube placement before intubation. 2

DSI Versus Standard RSI: Key Distinctions

Feature Standard RSI Delayed Sequence Intubation
Timing Induction agent and paralytic given simultaneously or in rapid succession [5] Ketamine given first, then 3-minute preoxygenation, then paralytic [2,3]
Preoxygenation Attempted before any medications [5] Performed AFTER ketamine, during dissociation [2]
Patient cooperation Required for effective preoxygenation [1] Not required; ketamine enables cooperation [2]
Apnea risk Begins immediately after paralytic [5] Delayed until after optimal preoxygenation achieved [2]

Critical Pitfalls and How to Avoid Them

Pitfall 1: Inadequate Post-Intubation Sedation

  • The problem: Ketamine's dissociative effects dissipate within 10–15 minutes, but rocuronium-induced paralysis lasts 30–60 minutes, creating a window where patients are paralyzed but inadequately sedated. 4
  • The solution: Implement protocolized post-intubation analgosedation immediately after successful intubation, ideally managed by a dedicated team member or clinical pharmacist. 4
  • Use standardized order sets that automatically trigger sedation protocols after rocuronium administration. 4

Pitfall 2: Using DSI When Standard RSI Is Appropriate

  • The problem: DSI is NOT a replacement for standard RSI in cooperative patients who can tolerate preoxygenation. 2
  • The solution: Reserve DSI specifically for agitated or delirious patients who actively resist preoxygenation efforts. 1, 2

Pitfall 3: Inadequate Preoxygenation Time

  • The problem: Rushing through the 3-minute preoxygenation window defeats the entire purpose of DSI. 2, 3
  • The solution: Use the full 3-minute preoxygenation period after ketamine administration to maximize oxygen reserves. 3
  • Monitor oxygen saturation continuously and target ≥98% before administering the paralytic. 2

Pitfall 4: Ketamine Dose-Related Hypotension

  • The problem: In critically ill patients with depleted catecholamine stores, ketamine may paradoxically cause hypotension despite its sympathomimetic properties. 4
  • The solution: Have vasopressors immediately available and consider using the lower end of the ketamine dosing range (1 mg/kg) in hemodynamically compromised patients. 4

Pitfall 5: Awareness Risk with Rocuronium

  • The problem: The incidence of explicit recall during emergency intubation is approximately 2.6%, and rocuronium's longer duration compared to succinylcholine (5–10 minutes) may prevent patient movement that would otherwise alert staff to inadequate sedation. 4
  • The solution: Protocolized post-intubation analgosedation reduces awareness risk substantially. 4
  • Have sugammadex 16 mg/kg available for reversal if a "can't intubate, can't ventilate" scenario develops. 5

Contraindications and Cautions

Relative contraindications to ketamine in DSI:

  • Severe cardiovascular instability with depleted catecholamine stores (risk of paradoxical hypotension). 4
  • Elevated intracranial pressure concerns are not an absolute contraindication, as ketamine's sympathomimetic properties help maintain cerebral perfusion pressure. 4

When DSI may not be appropriate:

  • Patients who can cooperate with standard preoxygenation should receive conventional RSI. 2
  • "Can't intubate, can't ventilate" scenarios require immediate front-of-neck access, not DSI. 5

Practical Implementation Tips

  • Position the patient: Use semi-Fowler position (head and trunk elevated 20–25°) during DSI to improve oxygenation and reduce aspiration risk. 1, 5
  • Optimize oxygen delivery: Apply nasal oxygen at 5 L/min during ketamine administration, then increase to 15 L/min after loss of consciousness and continue throughout intubation. 1
  • Consider NIPPV: In patients with severe hypoxemia (PaO₂/FiO₂ <150), use NIPPV during the preoxygenation phase after ketamine administration. 4
  • Team communication: Brief the team that you are performing DSI (not standard RSI) so everyone understands the 3-minute preoxygenation window before paralysis. 1
  • Document clearly: Record baseline oxygen saturation, post-ketamine saturation, and pre-paralysis saturation to demonstrate the effectiveness of your preoxygenation. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rapid Sequence Induction Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the downsides to delayed sequence intubation (DSI) in critically ill or injured patients, particularly those with chronic obstructive pulmonary disease (COPD) or other underlying respiratory diseases?
In which patient population is Delayed Sequence Intubation (DSI) more beneficial than Rapid Sequence Intubation (RSI)?
What is the recommended approach for rapid sequence intubation (RSI)?
What is the difference between a rapid sequence intubation (RSI) and a delayed sequence intubation?
What is the recommended intubation protocol for a patient with acute cholecystitis requiring emergency surgery?
What is the safe daily elemental potassium intake for a healthy adult with normal renal function not taking potassium‑sparing medications?
What Augmentin (amoxicillin‑clavulanate) dose should be given to an adult with end‑stage renal disease and acute bacterial sinusitis, and how should it be adjusted for hemodialysis or peritoneal dialysis?
How should I manage a patient on vitamin D 50,000 IU weekly and calcium 600 mg twice daily who remains vitamin D deficient with a 25‑hydroxyvitamin D level of 19.6 ng/mL and a low‑normal serum calcium of 8.2 mg/dL?
At what heart rate values does bradycardia or tachycardia become dangerous in adults?
What is the optimal antihypertensive therapy for a 33‑year‑old postpartum (2 weeks) woman with persistent hypertension after gestational hypertension who is breastfeeding?
What evidence‑based methods can be used to induce labor in a healthy 38‑week + 4‑day multiparous woman?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.